Skip to main content
. 2016 Nov 21;6(1):130–134. doi: 10.3892/mco.2016.1088

Table III.

Expression of ADMATS5 and recurrence.

ADAMTS5

Characteristic Low group (n=63) High group (n=62) P-value
Adjuvant chemotherapy 0.1277
  Yes 16 (25.40%) 24 (38.71%)
  No 47 (74.60%) 38 (61.29%)
Recurrence 1.000
  Yes 14 (22.22%) 13 (20.97%)
  No 49 (77.78%) 49 (79.03%)